1-3 of 3
Daniel A. Ritt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2152: TNIK, a novel activator of FAK and YAP signaling, is a therapeutic target in lung squamous cell carcinoma

Pedro Torres-Ayuso, Elvira An, Katherine M. Nyswaner, Daniel A. Ritt, Suzanne I. Specht, Sudipto Das, Thorkell Andresson, Christina M. Robinson, Simone Difilippantonio, Baktiar O. Karim, Benjamin E. Turk, Deborah K. Morrison, John Brognard
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2152.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2152
Published: 15 June 2022
View article
Journal Articles

Abstract LB-108: Targeting the Ras-Binding domain of RAS effector proteins by a small molecule inhibitor, Rigosertib

SaiKrishna Divakar, Rodrigo Vasqez-Del Caprio, Stacey J. Baker, M.V. Ramana Reddy, Daniel A. Ritt, Deborah K. Morrison, E. Premkumar Reddy
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-108.
DOI: https://doi.org/10.1158/1538-7445.AM2014-LB-108
Published: 01 October 2014
View article
Journal Articles

Abstract 1239: Differential effects of dimerization on B-Raf and C-Raf function revealed by mutational analysis and peptide inhibitors that target the Raf dimer interface

Alyson K. Freeman, Daniel A. Ritt, Deborah K. Morrison
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1239.
DOI: https://doi.org/10.1158/1538-7445.AM2012-1239
Published: 15 April 2012
View article